Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 0480-3684

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 0480-3684). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01.jpg (Image 1)

A line graph depicting mean concentration (ng/mL) over time (hours) for d-amphetamine and l-amphetamine from extended-release capsule formulations of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. Four data series compare a 37.5 mg capsule and a combination of MAS-ER 25 mg plus MAS-IR 12.5 mg, showing concentration peaks and decline rates up to 60 hours.*

FDA Label Image

Figure-02.jpg (Image 2)

A line graph comparing least-squares mean PERMP total scores over time post-dose (hours) between placebo and dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules. The graph shows two lines with error bars representing standard error, illustrating score changes from before dosing to 16 hours after.*

FDA Label Image

Label 12.5 mg (Image 3)

Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate extended-release capsules, 12.5 mg strength, containing 100 capsules in a once-daily dosage. The label includes dosage instructions, storage conditions, and the manufacturer Teva Pharmaceuticals, Inc., Parsippany, NJ. The label also features a barcode and NDC 0480-3683-01.*

FDA Label Image

Label 25 mg (Image 4)

Label for dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules, 25 mg strength. The label indicates once-daily oral dosage, contains 100 capsules per bottle, and is manufactured by Teva Pharmaceuticals, Inc. It includes storage instructions and a barcode within the serialization coding area.*

FDA Label Image

Label 37.5 mg (Image 5)

Label for dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules, 37.5 mg strength. The label indicates this is a mixed-salts single-entity amphetamine product, available as 100 capsules for once-daily oral use. Manufactured by Teva Pharmaceuticals, Parsippany, NJ. Includes directions for pharmacists and storage information.*

FDA Label Image

Label 50 mg (Image 6)

Label for extended-release capsules of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, 50 mg strength, manufactured by Teva Pharmaceuticals, Inc. The label states the product is for once-daily oral use, contains 100 capsules, and includes instructions for pharmacists to dispense an accompanying Medication Guide. Storage and handling instructions are also provided along with the NDC 0480-3686-01 and lot/expiration barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.